Get the Full Story, Without the Noise.
Published loading...Updated

The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives In a time of uncertainty, “react to the knowns, not the fear” - The Cancer Letter

Summary by The Cancer Letter
Thomas J. Lynch Jr. and Howard A. “Skip” Burris III lead two institutions that couldn’t be more different—an NCI-designated Comprehensive Cancer Center on one side of the country and a for-profit research enterprise on the other—but they stay up at nights worrying about the same thing: “Changing the paradigm of how research is funded and how care is funded, I think makes us all a bit nervous,” said Lynch, president and director of Fred Hutch Can…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Cancer Letter broke the news in on Friday, May 16, 2025.
Sources are mostly out of (0)